Skip to main content
. 2017 Jun 30;23:3192–3199. doi: 10.12659/MSM.901833

Figure 2.

Figure 2

TNF-α release identification in ovarian cancer cell lines SKOV3, IGROV-1, OVCAR8, and OV1063 upon PTS treatment of 0, 100, 200, and 500 μg/mL for 48 hours. Each experiment was done in triplicate and represented as mean ±SD: ‘a’ represents p<0.05, significant comparison with control of 0 μg/mL and ‘b’ represents p<0.05, significant comparison with 200 μg/mL treatment of PTS.